Back to JPMorgan Chase & Co. JPMorgan Chase & Co.

MRNAMRNA

9 quarters

Position history for JPMorgan Chase & Co.JPMorgan Chase & Co.'s holdings in Moderna, Inc.

Yes. JPMorgan Chase holds 2,564,570 shares of MRNA (Moderna), worth $525.8M, as of its Q3 2026 13F filing. It increased the position from 837,452 shares in Q2 2026. JPMorgan Chase has held MRNA in every 13F on record since Q3 2024, 9 quarterly filings.

Current Value

$525.8M

Current Shares

2.6M

Total Value Change

+$377M

Total Shares Change

+337,526

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
2.6M
+206.2%
$525.8M0.0%$192.57
51
2026-Q2
Decreased
837,452
-36.4%
$59.5M0.0%$70.03
0
2026-Q1
Increased
1.3M
+30.0%
$63.5M0.0%$50.80
37
2025-Q4
Decreased
1M
-26.9%
$29.9M0.0%$29.49
0
2025-Q3
Decreased
1.4M
-38.7%
$35.8M0.0%$25.83
0
2025-Q2
Increased
2.3M
+163.3%
$62.4M0.0%$27.59
48
2025-Q1
Increased
859,056
+64.2%
$24.4M0.0%$28.35
42
2024-Q4
Decreased
523,177
-76.5%
$21.8M0.0%$41.58
0
2024-Q3
First report
2.2M
—
$148.8M0.0%$66.83
0

Optional analytics helps us improve. How it’s used